Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD24 molecule is a highly glycosylated, GPI-anchored cell surface protein expressed on various immune (B and T lymphocytes, granulocytes, monocytes) and nonimmune cells (epithelial, neural, muscle). It modulates cellular adhesion, migration, differentiation, and proliferation, and plays a crucial role in immune regulation—negatively regulating inflammation and inducing apoptosis in some contexts. CD24 interacts with and regulates other adhesion molecules and immune cell surface receptors, impacting processes like homeostatic proliferation and immune checkpoint activity. Importantly, CD24 is associated with tumor progression, metastasis, and cancer stemness; consequently, it is being investigated both as a diagnostic biomarker and as a therapeutic target in cancer and other disease contexts. Clinical development of CD24-targeted therapies, including monoclonal antibodies and fusion proteins, is ongoing, but more evidence is needed regarding efficacy and safety. CD24’s functional complexity, tissue-specific roles, and impact on tumor biology position it as a promising but challenging therapeutic target.
Immune checkpoint modulation; Blockade of cell adhesion; Induction of apoptosis; Modulation of immune cell signaling (e.g., suppression of proliferation, regulation of cytokines)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD24 molecule (CD24).